Cargando…

Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD

This study evaluated the effects of cannabidiol (CBD) and/or sertraline (STR) on behavioral and gene expression alterations induced by a new chronic animal model of post-traumatic stress disorder (PTSD). C57BL/6J male mice were repeatedly exposed to physical and psychogenic alternate stressful stimu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gasparyan, Ani, Navarrete, Francisco, Manzanares, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273267/ https://www.ncbi.nlm.nih.gov/pubmed/34262461 http://dx.doi.org/10.3389/fphar.2021.694510

Ejemplares similares

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach
por: Navarro, Daniela, et al.
Publicado: (2023)

Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
por: García-Gutiérrez, María Salud, et al.
Publicado: (2023)

Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
por: García-Gutiérrez, María Salud, et al.
Publicado: (2022)

Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences
por: Navarrete, Francisco, et al.
Publicado: (2020)

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
por: Peres, Fernanda F., et al.
Publicado: (2018)

CB2 Receptor Involvement in the Treatment of Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Sertraline Induces Toxicity and Behavioral Alterations in Planarians
por: Thumé, Isabela Salvador, et al.
Publicado: (2017)

Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
por: Martínez-Orgado, José, et al.
Publicado: (2021)

Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
por: Navarro, Daniela, et al.
Publicado: (2022)

Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
por: García-Gutiérrez, Maria Salud, et al.
Publicado: (2020)

Cognitive Alterations in Addictive Disorders: A Translational Approach
por: Gasparyan, Ani, et al.
Publicado: (2023)

Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
por: Jurkus, Regimantas, et al.
Publicado: (2016)

The Impact of Cannabidiol on Human Brain Function: A Systematic Review
por: Batalla, Albert, et al.
Publicado: (2021)

Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: A review
por: Fu, Ze, et al.
Publicado: (2023)

Cannabidiol markedly alleviates skin and liver fibrosis
por: del Río, Carmen, et al.
Publicado: (2022)

A Case of Comorbid PTSD and Posttraumatic OCD Treated with Sertraline-Aripiprazole Augmentation
por: Rossi, Rodolfo, et al.
Publicado: (2020)

Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
por: Song, Chenchen, et al.
Publicado: (2016)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

Biomarkers of the Endocannabinoid System in Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2022)

Pairing Binge Drinking and a High-Fat Diet in Adolescence Modulates the Inflammatory Effects of Subsequent Alcohol Consumption in Mice
por: González-Portilla, Macarena, et al.
Publicado: (2021)

Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model
por: Shapiro, Lindsey, et al.
Publicado: (2022)

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
por: De Ternay, Julia, et al.
Publicado: (2019)

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
por: Scarante, Franciele F., et al.
Publicado: (2021)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
por: Austrich-Olivares, Amaya, et al.
Publicado: (2022)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
por: Bin Kanner, Yuval, et al.
Publicado: (2023)

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
por: Peres, Fernanda F., et al.
Publicado: (2016)

Functional characterization of cannabidiol effect on the serotonergic neurons of the dorsal raphe nucleus in rat brain slices
por: Mendiguren, Aitziber, et al.
Publicado: (2022)

Effects of Tibetan medicine metacinnabar (β-HgS) combined with imipramine or sertraline on depression-like symptoms in mice
por: Qiao, Yajun, et al.
Publicado: (2022)

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018)

Cannabidiol Reduces Leukemic Cell Size – But Is It Important?
por: Kalenderoglou, Nikoletta, et al.
Publicado: (2017)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
por: Montoya, Zackary, et al.
Publicado: (2020)

Cannabidiol for neurodegenerative disorders: A comprehensive review
por: Bhunia, Sukanya, et al.
Publicado: (2022)

Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury
por: Belardo, Carmela, et al.
Publicado: (2019)

Targeting neurosteroidogenesis as therapy for PTSD
por: Pinna, Graziano
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_66t8pbeenihl6jfcfvlrg8u3el